Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with prebiotics

Documents similaires

• Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with postbiotics
  par: Hania Szajewska, et autres
  Publié: (2025)
• Technical review by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications on the health outcomes of infant formula supplemented with manufactured human milk oligosaccharides
  par: Iva Hojsak, et autres
  Publié: (2025)
• Recommendations on the health outcomes of infant formula supplemented with biotics by the ESPGHAN Special Interest Group on Gut Microbiota and Modifications
  par: Ener Cagri Dinleyici, et autres
  Publié: (2025)
• Prebiotics in the management of pediatric gastrointestinal disorders: Position paper of the ESPGHAN special interest group on gut microbiota and modifications
  par: Flavia Indrio, et autres
  Publié: (2024)
• Reevaluating the FDA's warning against the use of probiotics in preterm neonates: A societal statement by ESPGHAN and EFCNI
  par: Chris H. P. van den Akker, et autres
  Publié: (2024)